Cysteine cathepsin protease inhibition: an update on its diagnostic, prognostic and therapeutic potential in cancer

Soond, SM; Kozhevnikova, MV; Townsend, Paul A; Zamyatnin, AA

dc.contributor.author	Soond, SM
dc.contributor.author	Kozhevnikova, MV
dc.contributor.author	Townsend, Paul A
dc.contributor.author	Zamyatnin, AA
dc.date.accessioned	2019-08-05T12:24:47Z
dc.date.available	2019-08-05T12:24:47Z
dc.date.issued	2019	en
dc.identifier.citation	Soond SM, Kozhevnikova MV, Townsend PA, Zamyatnin AA, Jr. Cysteine cathepsin protease inhibition: an update on its diagnostic, prognostic and therapeutic potential in cancer. Pharmaceuticals (Basel). 2019 Jun 11;12(2).	en
dc.identifier.pmid	31212661	en
dc.identifier.doi	10.3390/ph12020087	en
dc.identifier.uri	http://hdl.handle.net/10541/621956
dc.description.abstract	In keeping with recent developments in basic research; the importance of the Cathepsins as targets in cancer therapy have taken on increasing importance and given rise to a number of key areas of interest in the clinical setting. In keeping with driving basic research in this area in a translational direction; recent findings have given rise to a number of exciting developments in the areas of cancer diagnosis; prognosis and therapeutic development. As a fast-moving area of research; the focus of this review brings together the latest findings and highlights the translational significance of these developments.	en
dc.language.iso	en	en
dc.relation.url	https://dx.doi.org/10.3390/ph12020087	en
dc.title	Cysteine cathepsin protease inhibition: an update on its diagnostic, prognostic and therapeutic potential in cancer	en
dc.type	Article	en
dc.contributor.department	Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya str. 8-2, 119991 Moscow, Russia.	en
dc.identifier.journal	Pharmaceuticals	en
dc.description.note		en]
refterms.dateFOA	2019-08-06T14:53:26Z